The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland:

Size: px
Start display at page:

Download "The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland:"

Transcription

1 European Journal of Public Health, Vol. 21, No. 5, ß The Author 21. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved. doi:1.193/eurpub/ckq15 Advance Access published on 4 November The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: Julia Del Amo 1,2,3, Giedrius Likatavičius 4, Santiago Pérez-Cachafeiro 1,2, Victoria Hernando 1,2, Cristina González 1,2, Inma Jarrín 1,2, Teymur Noori 4, Françoise F. Hamers 5, Francisco Bolúmar 2,6 1 National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain 2 Ciber de Epidemiologia y Salud Pública (CIBERESP), Spain 3 Department of Health Sciences, University Rey Juan Carlos I, Madrid, Spain 4 Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden 5 Haute Autorité de Santé, Saint Denis, Paris, France 6 Department of Public Health Sciences, Universidad de Alcalá, Madrid, Spain Correspondence: Julia del Amo, National Center of Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos, , Madrid, Spain, tel: , fax: , jdamo@isciii.es Received 15 March 21, accepted 27 August 21 Background: To describe the epidemiology of HIV and AIDS by geographical origin in the EU, Methods: AIDS and HIV cases from the EU 27, Norway and Iceland reported to European Centre for Epidemiological Monitoring of AIDS were analysed. Results: Of AIDS reports over , 35% were migrants. Of 2988 heterosexual AIDS reports in 26, 5% were migrants, largely from Sub-Saharan Africa (SSA), 2% of 144 AIDS cases in men who have sex with men (MSM) were migrants from Latin-America and Western Europe. Of 57 mother-to-child transmission (MTCT) AIDS cases, 23% were from SSA. AIDS cases decreased from 1999 to 26 in natives (42%), Western Europeans (4%) and North Africa and Middle East (34%), but increased in people from SSA (by 89%), Eastern Europe (by 2%) and Latin-America (5%). Of HIV infections in men and 966 in females in 26, 49 and 76% were migrants, largely from SSA. Of 169 MTCT infections, 41% were from SSA. Conclusion: Migrants, largely from SSA, represent a considerable proportion of AIDS and HIV reports in EU, especially among heterosexual and MTCT infections. Their contribution is higher among female reports. A substantial percentage of diagnoses in MSM are migrants, largely from Western Europe and Latin-America. Keywords: acquired immunodeficiency syndrome, epidemiology, Europe, HIV infections, transient, migrants... Introduction he global HIV/AIDS pandemic reflects the gross socio- and gender inequalities between industrialized Teconomic and non-industrialized countries. In 27, 33 million people were living with HIV/AIDS (PLWHA) and >96% of the new HIV infections took place in low- and middle-income countries. 1 Of all PLWHA, 22.5 million live in Sub-Saharan Africa (SSA) where adult HIV prevalence is 5%, considerably higher than the.8% HIV world estimate. The Caribbean, with 1% prevalence, ranks second followed by Eastern Europe, with a.9% HIV prevalence. The female-to-male ratio of new HIV infections is significantly higher in SSA and The Caribbean than in Western countries. 1 According to the International Organization of Migration, 2 million people, 49.6% women, were international migrants in The United Nations (UN) defines an international migrant as anyone who changes his/her country of usual residence. 2 The most common push factor for migration is seeking an economic improvement. This economic gradient, coupled with demographic imbalances worldwide, explains why two-thirds of migrants travel from developing to developed countries. 2 Apart from economic migration, political and social dissidence force people to migrate. Particularly relevant to HIV epidemiology is the group of people who are persecuted because of their sexual identity. In 25, Europe had 64 million international migrants representing 8.8% of the population, 3 and the largest proportions of these migrants were born in neighbouring countries. The guidelines on HIV/AIDS and human rights developed by the UN Office of the High Commissioner for Human Rights and the Joint United Programme on HIV recognized migrants as one of the most vulnerable groups to HIV infection and its consequences. 4 These guidelines call upon governments to fulfil their obligations on non-discrimination, rights to health and employment to reduce their vulnerability. 4 The HIV epidemic is a major public health problem in the EU; the number of HIV infections has not ceased to increase since HIV reporting mechanisms came into place around ,6 Heterosexually transmitted HIV infection accounts for the largest number of people with HIV in Europe; a considerable proportion of these HIV cases are migrants, largely from SSA. 5,6 Male-to-male sex accounts for most of the ongoing HIV transmission at EU level but hardly any data on the geographical origin of these men are available. Since 1998, former EuroHIV collects information on the geographical origin of all cases irrespective of their transmission category. The rationale behind this move was that health inequalities, including those by migrant status, need to be Downloaded from on 3 January 218

2 Epidemiology of HIV infection in Europe 621 monitored for developing appropriate responses. We aim to describe the epidemiology of reported HIV infections and AIDS cases according to geographical origin, sex and transmission category in the EU 27, Norway and Iceland in Methods We used AIDS cases and HIV infections from National registries from the EU 27, Norway and Iceland reported to former EuroHIV, now based at the European Centre for Disease Prevention and Control (ECDC), from 1999 to 26. Data on AIDS diagnoses were adjusted for reporting delays. HIV data were reported as date of notification. Since 1998, EuroHIV collected information on the origin of HIV/AIDS cases. It was recommended to derive this information from nationality or country of birth. The variable was classified as: people whose origin is the same as the reporting country, West Europe, Central Europe, East Europe, SSA, East Asia and Pacific, Australia and New Zealand, South and Southeast Asia, North Africa and Middle East, North America, Caribbean, Latin-America, Foreigner and unknown. We examined absolute numbers and proportions of migrants according to geographical origin among AIDS and HIV reports from 1999 to 26, stratified by sex and transmission category. We calculated relative changes in the number of AIDS cases in 26 compared with We plotted the proportion of migrants among HIV infections reported in 26 by country classified in five groups according to estimated HIV incidence per million people. 6 Results Of the AIDS cases ( were men) reported from 1999 to 26, (35%) were migrants. The proportion of migrants among the female AIDS cases, 46%, was higher than in male AIDS cases, 31%. Out of 6746 AIDS reports, 2472 (37%) were migrants (table 1) in 26. The proportion of women among AIDS cases in migrants (4%) was higher than in cases whose geographical origin was the reporting country (28%). The 62 AIDS reports in SSA men and the 623 in SSA women accounted for 12 and 33% of the total number of AIDS cases reported for each sex in 26. The number of AIDS cases in the European region experienced a 42% decline from 1999 to 26 in natives and migrants from Western Europe, but increases are observed in migrants from Eastern Europe (by 2%), SSA (by 89%) and Latin-America (by 5%). The largest number, in absolute and relative terms, of migrants among AIDS reports from 1999 to 26 is observed in heterosexually transmitted cases (figure 1). Of all the heterosexual AIDS reports with known geographical origin in 26, 1373 (5%) were from a country different to that reporting the case, largely from SSA (figure 1). Of 57 AIDS cases reported in 26 due to mother-to-child transmission (MTCT) with known geographical origin, 23% were from SSA. Also, close to 2% of AIDS cases in men having sex with men (MSM) were migrants and the commonest origins were Latin-America and other Western European countries. Among 1545 cases in IDU diagnosed during 26, 7% were migrants, largely from Western Europe and North Africa and Middle East (figure 1). Marked increases from 1999 to 26 in the number of heterosexuals from SSA among AIDS cases are seen (figure 1). The proportion of migrants from Latin-America (3.% in 1999 vs. 7.5% in 26) and Western Europe (2.9% in 1999 vs. 3.6% in 26) among AIDS reports in MSM has also increased (figure 1). From 1999 to 26, of the tuberculosis (TB) cases reported as initial AIDS-defining condition (ADC), 828 were migrants (3883 from SSA) and 2684 had unknown Table 1 Distribution by geographical origin and sex of AIDS cases and number of newly diagnosed HIV infections reported in 26 Total Male Female AIDS cases Total Cases in migrants Geographical origin of cases Country of report West Europe a Centre Europe b East Europe c Sub Saharan Africa East Asia and Pacific 1 1 Australia and New Zealand 1 1 South and southeast Asia North Africa and Middle East North America Caribbean Latin-America Others Unknown HIV infections d Total Cases in migrants Geographical origin of cases Country of report West Europe Centre Europe East Europe Sub Saharan Africa East Asia and Pacific Australia and New Zealand South and southeast Asia North Africa and Middle East North America Caribbean Latin-America Others Unknown a: West Europe countries: Andorra, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, UK. b: Centre Europe countries: Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Hungary, Former Yugoslav Republic of Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, Turkey. c: East Europe countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Republic of Moldova, Russian Federation, Tajikistan, Turkmenistan, Ukraine, Uzbekistan. d: All EU countries except Bulgaria, Italy, Malta and Rumania due to missing HIV data. geographical origin. Prevalence of TB as initial ADC was 4% in Sub-Saharan Africans, 4% in Eastern Europeans, 32% in Southeast Asians, 3% in Latin-Americans, 16% in natives and 8% in North-Americans (figure 2). Among heterosexuals, TB represented 3499 (41%) of initial ADC in Sub-Saharan Africans, 26 (46%) in Eastern Europeans, 173 (32%) in Southeast Asians, 255 (15%) in natives and between 2% and 25% in people from Central Europe, North Africa and Middle East, Caribbean and Latin-America. Prevalence of TB was higher in Injecting drug user (IDU), followed by heterosexuals, compared with MSM but the differences by geographical origin are maintained (data not shown). In 26, of HIV infections reported, (58%) were migrants and 7812 (29%) did not record the geographical Downloaded from on 3 January 218

3 622 European Journal of Public Health 25 Men who have sex with men 4 35 IDU (n=2496) 2 (n=2365) 21 (n=1937) 22 (n=192) 23 (n=1911) 24 (n=1823) 25 (n=1776) 26 (n=141) 1999 (n=441) 2 (n=3463) 21 (n=314) 22 (n=2778) 23 (n=2587) 24 (n=229) 25 (n=24) 26 (n=1557) Natives East Europe Australia & New Zealand North America Others West Europe Sub Saharan Africa South & south-east Asia Caribbean Unknown Centre Europe East Asia & Pacific North Africa & Middle East Latin America 4 Heterosexual 12 MTCT (n=3355) 2 (n=3544) 21 (n=3551) 22 (n=389) 23 (n=3777) 24 (n=3741) 25 (n=3589) 26 (n=2989) 1999 (n=19) 2 (n=19) 21 (n=93) 22 (n=85) 23 (n=88) 24 (n=73) 25 (n=6) 26 (n=61) Figure 1 Trends in AIDS cases by geographical origin within each transmission category: % 4% 39,7% 4,% 36,6% 3% 2% 16,4% 21,2% 19,9% 19,7% 31,7% 23,3% 23,5% 3,1% 26,7% 1% 8,% % Natives (8,28/48,962) West Europe (279/1,318) Centre Europe (114/573) East Europe (58/146) Sub Saharan Africa (3,883/9,711) East Asia & Pacific (12/61) South & Southeast Asi (267/843) North Africa & Middle East (218/937) North America (9/113) Caribbean (166/75) Latin America (44/1,463) Others (67/183) Unknown (2,684/1,56) Country of origin Figure 2 Cumulative percentage of TB as the initial AIDS-defining condition in AIDS cases reported, Downloaded from on 3 January 218

4 Epidemiology of HIV infection in Europe Men who have sex with men 35 IDU (n=2858) 2 (n=363) 21 (n=2768) 22 (n=3648) 23 (n=493) 24 (n=65) 25 (n=698) 26 (n=6616) 1999 (n=152) 2 (n=3537) 21 (n=262) 22 (n=2511) 23 (n=2149) 24 (n=2218) 25 (n=194) 26 (n=1612) Natives West Europe Centre Europe East Europe Sub Saharan Africa East Asia & Pacific Australia & New Zealand South & south-east Asia North Africa & Middle East North America Caribbean Latin America Others Unknown 15 Heterosexual 3 MTCT (n=359) 2 (n=452) 21 (n=4868) 22 (n=6366) 23 (n=956) 24 (n=1144) 25 (n=11429) 26 (n=9944) 1999 (n=124) 2 (n=176) 21 (n=163) 22 (n=22) 23 (n=258) 24 (n=298) 25 (n=237) 26 (n=191) Figure 3 Trends in HIV cases by geographical origin within each transmission category: origin (table 1). The proportion of women (44%) among HIV reports in migrants was higher than in natives (34%). People from SSA are the second largest group among HIV reports in the EU (table 1), migrants from other Western European country are the third, followed by Latin-Americans, Southeast Asians and Caribbeans (table 1). The numbers of men and women from SSA among HIV infections reported in 26 were 191 and 3145, respectively (table 1). The number of HIV reports in women from SSA exceeds by close to 1 that of native women and by over 1 that of men from SSA. It has to be acknowledged that there are 291 HIV infections in females with unknown geographical origin. After SSA, those from Western Europe account for the largest group followed by Latin-Americans. After Sub-Saharan African women, the most common origins of HIV infections in female migrants were Southeast Asia and Caribbean (table 1). As it can be seen in figure 3, the number of HIV reports acquired heterosexually in migrants ceased to increase by 26, and even a slight decline was observed, coupled with a slight increase in the number of cases with unknown geographical origin. The largest number of migrants, both in absolute and relative terms, was observed among heterosexually transmitted infections whose commonest origin was SSA (figure 3). Of the Downloaded from on 3 January MTCT HIV reports with known geographical origin, 41% were from SSA (figure 3). Of the 548 HIV infections with known geographical origin in MSM, 18% were migrants and the commonest regions of origin were Western Europe, Latin-America and North-Africa and Middle East. Among the 159 HIV infections in IDU with known geographical origin, 14% migrants, largely from Western and Eastern Europe (figure 3). Interpreting absolute trends between 1999 and 26 is difficult due to the major changes in the implementation of the HIV reporting systems and it seems that the relative contribution of migrants to the HIV infections reported has increased over time for all transmission categories, especially in heterosexuals (figure 3). There is substantial heterogeneity in the proportion of migrants among HIV reports between countries (figure 4). Among countries with HIV incidence below 2 cases per million, largely Central Europe, the proportion of migrants among HIV reports is low, while is higher for most of the countries with high HIV incidence, with notable exceptions like Estonia. Finally, for most countries, the most common region of origin of the AIDS and HIV reports was SSA, with some exceptions like Spain where the absolute number of people from Latin-America outnumbered that of SSA.

5 624 European Journal of Public Health Poland Slovakia > <2 Slovenia Hungary Czech Republic Lithuania Spain** Denmark Finland Iceland Sweden Chipre Greece Germany France Netherlands Belgium Ireland Norway Latvia Austria United Kingdom* Luxembourg Estonia Portugal % 2% 4% 6% 8% 1% migrant HIV cases native cases origin unkown * Unknown origin: UK collected in country of probable infection of which missing information was observed in 24% of cases ** Spain data: 25 Figure 4 Proportion of migrants among HIV infections reported in 26 in 23 EU countries plus Norway and Iceland. Countries are classified in five groups according to HIV incidence rates per million populations. Asterisk indicates unknown origin: based in country of probable infection, missing information was observed in 24% of cases and double asterisk indicate Spain data: 25 Discussion Migrant populations, largely Sub-Saharan Africans, represented a considerable and growing proportion of both AIDS cases and HIV infections reported in the 27 EU countries, Norway and Iceland during The drop in AIDS cases observed in native populations is seen only in migrants from Western countries, while in migrants from other geographical origins increases are seen. The contribution of migrants to the AIDS and HIV epidemics is notably higher among female reports, in particular for women from SSA. Closely linked to the high burden of HIV infection in women from SSA is the high proportion of migrants from SSA among MTCH HIV reports. Although the largest proportion of migrants is, by far, among heterosexually acquired HIV and AIDS reports, a significant percentage of Downloaded from on 3 January 218 diagnoses in MSM are also migrants, largely from Western Europe and Latin-America and North-Africa and Middle East. A higher proportion of migrants developed TB as their initial ADC compared with natives; people from SSA and Eastern Europe had the highest prevalence of TB, closely followed by people from Southeast Asia. There is substantial heterogeneity in the proportion of migrants among AIDS cases and HIV infections between EU countries being notably higher in Northern and Western EU countries compared with Eastern and Central EU. The number of AIDS reports from most EU countries experienced a marked decline from the mid-199s onwards, largely attributed to the impact of High Activity Antiretroviral Therapy (HAART). 6,7 However, for migrants from outside Western European countries actual increases are observed that may respond to late diagnosis of HIV

6 Epidemiology of HIV infection in Europe 625 infection, poor access and response to HAART or immigration of people with advanced HIV disease. Our results are in line with an article by Prost et al., where authors identify that the features affecting Sub-Saharan African migrants living with HIV/AIDS in Europe are more advanced disease at diagnosis, higher TB rates, major difficulties related to immigration status, social discrimination and stigma and high levels of poverty and unemployment. 8 Delayed diagnosis of HIV infection is a major public health problem in the EU, and various publications suggest that this trend is commoner in migrants Poorer response to HAART has also been described. 14 The contribution of migrants to national HIV epidemics is heterogeneous in the EU as it depends on migration patterns, neo-colonial history, state of HIV epidemics in countries of origin and destination and health and social responses. The heterogeneity in the proportion of migrants among HIV/ AIDS cases between the EU found in this study is consistent with migratory trends; countries with high proportion of migrants among HIV cases are also the countries with higher proportion of migrants in the general population. 15 The contribution of migrants, largely from SSA, to the number of HIV reports in the EU is higher in female reports. Among HIV reports in women with known geographical origin, the number of HIV-positive women from SSA outnumbers that of native women and that of HIV-positive African men, whereas the number of registered African women in population registries across the EU does not outnumber that of African men. 15 Acknowledging the limitations resulting from a high proportion of missing information and various possible explanations such as selective HIV testing of women from SSA during pregnancy, these data suggest that women from SSA, not only in their countries of origin, but also when migrating to another country, suffer a greater burden of HIV disease. 1 The reasons for female vulnerability to HIV infection have both social and biological bases 16 and the need to address gender vulnerability within migrants is needed. 17 Closely linked to the high burden of HIV infection in women from SSA is the high proportion of migrants from SSA among MTCH reports. Close to 4% of the HIV infections through MTCT were from SSA and this proportion has increased from 1999 to 26. Given that geographical origin is not always equivalent to country of birth and acknowledging that some of these children may have been born to HIV-infected mothers outside the EU, it is likely that some of these children have been infected by HIV due to failure to diagnose and treat their mothers in the EU. While the decreases in perinatal HIV infections in the EU represent an important achievement in public health, substantial challenges remain, particularly among migrant mothers. 18,19 In France, testing during pregnancy was the commonest reason to diagnose HIV in women from SSA. 19 Though HIV-positive African women presented later to antenatal care, once they accessed, uptake of HIV treatment and elective caesarean section was the same than French women. 19 We have identified a considerable proportion of migrants among HIV diagnoses in MSM, mainly from other Western EU countries, Latin-America and North-Africa and Middle East. MSM are hardly ever acknowledged when addressing the HIV epidemic in migrant populations. 2 Although numerically inferior to heterosexuals, their contribution is not negligible and it has distinct characteristics. MSM may share with the heterosexual population some reasons to migrate but also have specific reasons related to homophobia. While homophobia may certainly be a driving factor for abandoning ones country in MSM from Western countries, it is more of an issue for MSM from many countries where basic human rights for gay people are violated. These figures Downloaded from on 3 January 218 highlight the need to acknowledge the sexual diversity of migrants living with HIV/AIDS in Europe. These data do not allow distinguishing where actually HIV infection occurred. Other reports suggest that most heterosexually acquired HIV infections among Sub-Saharan Africans are likely to have been acquired in countries of origin. 21,22 Recently, Burns et al. have published that as many as a quarter of HIV infections diagnosed among heterosexuals and half among gay men from SSA acquired the infection in the UK. 23 Given that the majority of people tend to choose sexual partners within their own communities, assortative sexual mixing may take place. 24 Fenton et al., documented the high proportion of people engaging in unprotected sex when travelling to home countries. 25 Discussing country of probable infection is extremely controversial as it has, unfortunately, given rise to racist reactions but understanding where HIV infections and development of AIDS take place has important implications from a public health perspective as it may represent failure in primary HIV prevention, secondary HIV prevention or both. These data have to be interpreted in the context of certain limitations. Former EuroHIV recommended deriving information on geographical origin from nationality or from country of birth which may lead to misclassification. 26 The role of selective HIV testing in migrants may also lead to overestimates of HIV prevalence when compared with groups not exposed to similar testing practices. This is particularly relevant for women from SSA who may be more exposed to antenatal HIV screening than men and native women who have lower numbers of children. The overall increase in HIV infections has to be interpreted in the context of the implementation of HIV reporting which is not yet complete and may have led to an overestimate of this trend. The absence of HIV reporting systems in some countries and poor completion of the variable geographical origin in others is a caveat in interpreting figures. Finally, most countries do not collect information on ethnic background in healthinformation systems and in many it is not allowed. 26 It is likely that HIV is affecting disproportionately ethnic minorities in the EU who are currently invisible to surveillance systems that will be classified as natives as their country of origin is the same as the country of report. The most recent ECDC figures from the surveillance strategy also reflect the high proportion of migrants among HIV-positive people in all transmission categories. Although some variable coding changes may hamper complete comparability with the data presented here, these most recent figures highlight that the number of new HIV diagnoses acquired heterosexually in migrants from countries with generalized epidemics seems to have halted. However, given the high number of missing values for the geographical origin variable, care has to be taken in interpreting these trends. 27 Our data confirms that failure of both primary and secondary HIV prevention in migrant populations is taking place, especially migrant women, and urgent action is needed. Controlling the HIV/AIDS epidemic implies breaking barriers to HIV prevention and treatment. 28 These barriers have a hierarchical structure and it has to be stated that in a framework of prosecution of migrants, irrespective of their administrative and legal residency status, public-health strategies and recommendations aimed to decrease language, cultural and gender barriers are bound to fail. Fear of deportation will abort many of the public-health initiatives aimed to prevent HIV and AIDS in migrants. Since the early days of the HIV epidemic, it became clear that ensuring the rights of the PLWHA were the pillars of the fight against the epidemic. This is still the framework that is needed to fight HIV/AIDS in migrant communities in the EU.

7 626 European Journal of Public Health Acknowledgements The authors are grateful for funds provided by CIBERESP (Spain) and RIS (RD6/6). Funding This work was commissioned by the ECDC as a restricted call for tende. Conflicts of interest: None declared. Key points These are the first data to quantify that migrants, largely from SSA, represent a considerable proportion of AIDS and HIV reports in EU, especially among heterosexual and MTCT infections, and that their contribution is higher among female reports. Although the largest proportion of migrants is, by far, among heterosexually acquired HIV and AIDS reports, a significant percentage of diagnoses in MSM are also migrants, largely from Western Europe and Latin-America and North-Africa and Middle East. A higher proportion of migrants developed TB as their initial ADC compared with natives. The declines seen in the number of AIDS cases in EU from the mid-199s onwards are not seen in migrants from outside Western European countries, where actual increases are observed. These data confirm that failure of both primary and secondary HIV prevention in migrant populations in Europe is taking place, especially migrant women, and urgent action is needed. References 1 UNAIDS. 28 Report on the Global AIDS Epidemic. Available at: (November 28, date last accessed). 2 International Organization for Migration. Available at: (November 28, date last accessed). 3 Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, Trends in Total Migrant Stock: The 25 Revision Availabe at: (3 May 29, date last accessed). 4 UNAIDS. International Guidelines on HIV/AIDS and Human Rights. 26 Consolidated Version. Available at: (November 28, date last accessed). 5 Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet 24;364: European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe: End-year report 26. N 75. Available at: (November 28, date last accessed). 7 CASCADE Collaboration.Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 23;362: Prost A, Elford J, Imrie J, et al. Social, behavioural, and intervention research among people of Sub-Saharan African origin living with HIV in the UK and Europe: literature review and recommendations for intervention. AIDS Behav 28;12: Coenen T, Lundgren J, Lazarus JV, Matic S. Optimal HIV testing and earlier care: the way forward in Europe. HIV Med 28;9(Suppl 2): Sobrino P, García L, Caro AM, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res 29;7: Lanoy E, Mary-Krause M, Tattevin P. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 27;12: Wolbers M, Bucher HC, Furrer H. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 28;9: Caro AM, Gutiérrez F, Ramos JM, et al. Infection in migrants in Spain: epidemiological characteristics and clinical presentation in the CoRIS Cohort, Enferm Infecc Microbiol Clin 29;27: Dray-Spira R, Spire B, Heard I, Lert F and VESPA Study Group. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study. AIDS 27;21(Suppl 1):S Eurostat. Available at: (November 28, date last accessed). 16 Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 25;38: Llácer A, Zunzunegui MV, Del Amo J, et al. The contribution of a gender perspective to the understanding of migrants health. J Epidemiol Comm Health 27;61(Suppl 2):ii Jasseron C, Mandelbrot L, Tubiana R, et al. ANRS French Perinatal Cohort. Prevention of mother-to-child HIV transmission: similar access for sub-sahara African immigrants and for French women? AIDS 28;22: Perinatal transmission of HIV in England: Available at: (November 28, date last accessed). 2 Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, AIDS 28;22: Dougan S, Elford J, Rice B, et al. Epidemiology of HIV among black and minority ethnic men who have sex with men in England and Wales. Sex Transm Infect 25;81: Sinka K, Mortimer J, Evans B, Morgan P. Impact of the HIV epidemic in sub-saharan Africa on the pattern of HIV in the UK. AIDS 23;17: Burns FM, Arthur G, Johnson AM, et al. SONHIA collaboration group. United Kingdom acquisition of HIV infection in African residents in London: more than previously thought. AIDS 29;23: Kramer MA, van Veen MG, de Coul EL, et al. Migrants travelling to their country of origin: a bridge population for HIV transmission? Sex Transm Infect 28;84: Fenton KA, Chinouya M, Davidson O, et al. the MAYISHA research team. HIV transmission risk among sub-saharan Africans in London travelling to their countries of origin. AIDS 21;15: Del Amo J, Broring G, Hamers F, et al. Monitoring HIV/AIDS in migrants communities in Europe. AIDS 24;18: European Center for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 28. Stockholm: ECDC, Fakoya I, Reynolds R, Caswell G, Shiripinda I. Barriers to HIV testing for migrant black Africans in Western Europe. HIV Med 28;9 (Suppl 2):23 5. Downloaded from on 3 January 218

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National

More information

European status report on alcohol and health Leadership, awareness and commitment

European status report on alcohol and health Leadership, awareness and commitment European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential

More information

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10% % of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected

More information

The cancer burden in the European Union and the European Region: the current situation and a way forward

The cancer burden in the European Union and the European Region: the current situation and a way forward The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers

More information

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of

More information

Alcohol-related harm in Europe and the WHO policy response

Alcohol-related harm in Europe and the WHO policy response Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related

More information

ECDC and Spanish Ministry of Health workshop:

ECDC and Spanish Ministry of Health workshop: ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,

More information

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej

More information

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Reflecting on ten years of progress in the fight against AIDS, TB and malaria Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:

More information

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. WHO/Europe publishes a weekly electronic bulletin on influenza activity in the Region 1 and

More information

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region: Summary. No. 21(February 2012) No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for

More information

Key issues for HIV testing and

Key issues for HIV testing and Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics

More information

European Status report on Alcohol and Health

European Status report on Alcohol and Health European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.

More information

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada

More information

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SWEDEN WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of

More information

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 HUNGARY WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising

More information

Access to treatment and disease burden

Access to treatment and disease burden Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor

More information

Q1 What age are you?

Q1 What age are you? Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%

More information

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella

More information

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

EURO POLIO PAGE Data as of 04 October 2005 (Week 38) World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:

More information

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 SERBIA WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising

More information

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous) Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous) 25 th Conference of the OIE Regional Commission for Europe 17 th to 21 st September 2012, Fleesensee Germany

More information

Where we stand in EFORT

Where we stand in EFORT Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section

More information

Summary. Primary care data. Week 49/2014. Season

Summary. Primary care data. Week 49/2014. Season Summary Week 49/2014 In week 49/2014, influenza activity remained low across the WHO European Region. Twenty countries reported sporadic influenza activity and nine reported increasing trends in consultations

More information

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest

More information

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium

More information

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT. SPECIAL REPORT Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report Summary www.ecdc.europa.eu ECDC SPECIAL REPORT Implementing the Dublin

More information

ECDC s role in the fight against HIV/AIDS in Europe

ECDC s role in the fight against HIV/AIDS in Europe European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November

More information

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist Undetectable = Untransmittable Mariah Wilberg Communications Specialist Undetectable=Untransmittable PLWH who get and stay undetectable have effectively no risk of transmitting HIV to their sex partners

More information

Inequality in injury risks

Inequality in injury risks Inequality in injury risks Rationale Injuries a are a neglected but preventable epidemic and in the 53 countries in the WHO European Region account for nearly 800 000 lives lost annually (equivalent to

More information

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,

More information

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches Environmental Approaches Consumption of 10+ and 21+ Drinks on an Occasion At Least Once in the Past Year, 2013 30 25 20 15 10+ drinks 15 25 10+ drinks 16 25 10 5 0 21+ drinks 3 2 21+ drinks 18-20 21-24

More information

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT EUDY JUNIOR CP 2018 FIRST ANNOUNCEMENT 21. 29. July 2018 Tesáre, SLOVAKIA IDENTITY OF THE DEAF EUROPEAN UNION OF THE DEAF YOUTH (EUDY) The European Union of the Deaf Youth is a European non-profit organisation

More information

11 Melanoma of the skin

11 Melanoma of the skin 11 Melanoma of the skin 11.1 Summary Melanoma of the skin is the ninth most common cancer in Ireland, accounting for 2.4 of all malignant neoplasia in men and 4.2 in women, if non-melanoma skin cancers

More information

Engagement in language assessment / Regions of Europe

Engagement in language assessment / Regions of Europe Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium

More information

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage A MONTHLY NEWSLETTER OF THE COMMUNICABLE DISEASE UNIT, WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE, COPENHAGEN, DENMARK Issue 5, March 2009 Analysis of 3-dose oral/inactivated poliovirus vaccine

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

Smokefree Policies in Europe: Are we there yet?

Smokefree Policies in Europe: Are we there yet? Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially

More information

LEBANON. WCPT COUNTRY PROFILE December 2018

LEBANON. WCPT COUNTRY PROFILE December 2018 LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000

More information

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region Zsuzsanna Jakab WHO Regional Director for Europe A big challenge Globally every year 7.6 million children die

More information

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets? Noncommunicable diseases progress monitoring Are we meeting the time-bound United Nations targets? Background paper for the WHO European Meeting of National NCD Directors and Programme Managers, Moscow,

More information

DENMARK. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018 DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000

More information

Cardiovascular disease in Europe: epidemiological update 2016

Cardiovascular disease in Europe: epidemiological update 2016 European Heart Journal (2016) 37, 3232 3245 doi:101093/eurheartj/ehw334 REVIEW Cardiovascular disease in Europe: epidemiological update 2016 Nick Townsend 1 *, Lauren Wilson 1, Prachi Bhatnagar 1, Kremlin

More information

HPAI H5(N8) in Member States in poultry, captive and wild birds

HPAI H5(N8) in Member States in poultry, captive and wild birds HPAI H5(N8) in Member States in poultry, captive and wild birds (01/10/2016-01/03/2017) DG Health and Food Safety 13,578,000 5,610,000 234,000 Broad migration flows of ducks across Europe 1,000,000 71,000

More information

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium tuberculosis.

More information

The challenge of obesity in the WHO European Region

The challenge of obesity in the WHO European Region Fact sheet EURO/13/05 Copenhagen, Bucharest, 12 September 2005 The challenge of obesity in the WHO European Region Obesity poses one of the greatest public health challenges for the 21st century, with

More information

Table 9.1 Summary information for stomach cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland, 9 Stomach cancer 9.1 Summary Stomach cancer ranks seventh in terms of the most common cancers in Ireland, accounting for 4.1% of all malignant neoplasia in men and 2.8% in women, when non-melanoma skin

More information

Welcome to the new EURO Immunization Monitor

Welcome to the new EURO Immunization Monitor Welcome to the new EURO Immunization Monitor The Communicable Diseases Unit of the WHO Regional Office for Europe is charged with maintaining the fight against infectious diseases. One of the priority

More information

European Collaboration on Dementia. Luxembourg, 13 December 2006

European Collaboration on Dementia. Luxembourg, 13 December 2006 European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,

More information

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Syphilis Key facts In 2015, 28 701 syphilis cases were reported in 29 EU/EEA Member States (data were not available from Austria and Liechtenstein),

More information

GERMANY. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018 GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

Table 7.1 Summary information for lung cancer in Ireland,

Table 7.1 Summary information for lung cancer in Ireland, 7 Lung cancer 7.1 Summary Lung cancer is the third most common cancer in Ireland, accounting for 15% of cancers in men and 9% in women, if non-melanoma skin cancer is excluded (table 7.1). Each year, approximately

More information

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT UNITED NATIONS A General Assembly Distr. LIMITED A/HRC/11/L.16 16 June 2009 Original: ENGLISH HUMAN RIGHTS COUNCIL Eleventh session Agenda item 3 PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL,

More information

Better Health for All in Latvia

Better Health for All in Latvia Better Health for All in Latvia The health strategy for the European Region (Health 2020) and the Latvian Public Health Strategy 2011 2017 Zsuzsanna Jakab WHO Regional Director for Europe 18 April 2011,

More information

Behavioural indicators in men who have sex with men

Behavioural indicators in men who have sex with men Behavioural indicators in men who have sex with men Dr. Brenda Spencer, IUMSP, Lausanne 13 th HIV/AIDS Think Tank Meeting First presented by Prof. Jonathan Elford, City University London European Parliament,

More information

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)

More information

Main developments in past 24 hours

Main developments in past 24 hours ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance

More information

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.

More information

Best practices in collecting and processing data in CRC screening and after it

Best practices in collecting and processing data in CRC screening and after it Best practices in collecting and processing data in CRC screening and after it The potential of harmonized information policy in effective national implementation of CRC screening Ladislav Dušek, Czech

More information

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

Hepatitis C in the WHO European Region

Hepatitis C in the WHO European Region Hepatitis C in the WHO European Region Antons Mozalevskis WHO Regional Office for Europe Drug-related infectious disease (DRID) annual expert meeting 15 16 June 2015, EMCDDA Lisbon Burden of viral hepatitis

More information

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT EUDY CHILDREN CP 2017 FIRST ANNONUCEMENT 08 15 July 2017 Prašník Dúbrava, SLOVAKIA THE IDENTITY OF A YOUNG DEAF CHILD EUROPEAN UNION OF THE DEAF YOUTH (EUDY) The European Union of the Deaf Youth is a European

More information

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015 European Union European Union WHO Collaborating OIE Reference Reference Centre Reference NANCY LABORATORY FOR RABIES AND WILDLIFE Laboratory for Rabies Institute for Rabies Serology for Research and Management

More information

Development of Palliative Care services in different countries

Development of Palliative Care services in different countries Development of Palliative Care services in different countries Nicoleta Mitrea EONS leadership summit, 2017 Disclosure speaker Do you have any interest to declare? No, I don t have any interest to declare.

More information

Key Highlights continued

Key Highlights continued Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family

More information

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Department of Biological Standardisation OMCL Network & Healthcare (DBO) Department of Biological Standardisation OMCL Network & Healthcare (DBO) Implementation of Pathogen Reduction Technologies for Blood Components for Transfusion: Updated Table 2009-2010 COUNCIL OF EUROPE

More information

European Association of Dental Public Health Prevention of Oral Cancer

European Association of Dental Public Health Prevention of Oral Cancer European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013

More information

ICM: Trade-offs in the fight against HIV/AIDS

ICM: Trade-offs in the fight against HIV/AIDS ICM: Trade-offs in the fight against HIV/AIDS 1 As the HIV/AIDS pandemic enters its 25 th year, both the number of infections and number of deaths due to the disease continue to rise. Despite an enormous

More information

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the

More information

Lymphogranuloma venereum

Lymphogranuloma venereum Annual Epidemiological Report for 2015 Lymphogranuloma venereum Key facts In 2015, 1 787 cases of Lymphogranuloma venereum (LGV) were reported in 23 countries. Three countries (France, the Netherlands

More information

Fakoya et al. BMC Public Health (2015) 15:561 DOI /s

Fakoya et al. BMC Public Health (2015) 15:561 DOI /s Fakoya et al. BMC Public Health (2015) 15:561 DOI 10.1186/s12889-015-1852-9 RESEARCH ARTICLE Open Access A systematic review of post-migration acquisition of HIV among migrants from countries with generalised

More information

HIV/AIDS Joint Action HA-REACT

HIV/AIDS Joint Action HA-REACT HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission

More information

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries 1 Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries Introduction Mariachiara Di Cesare and Mike Murphy Department of Social Policy, London

More information

THE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response.

THE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response. THE BENCHMARK UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response. THE BENCHMARK UNAIDS and the polling company Zogby International

More information

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ ) 1 / 11 Region/Subregion/ Country Africa Eastern Africa Kenya Madagascar Mauritius Uganda United Republic of Tanzania Northern Africa Algeria Egypt Libya Morocco Sudan Southern Africa Botswana Burkina Faso

More information

Scaling up priority HIV/AIDS interventions in the health sector

Scaling up priority HIV/AIDS interventions in the health sector TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

Childlessness in Europe: Reconstructing long-term trends among women born in

Childlessness in Europe: Reconstructing long-term trends among women born in Childlessness in Europe: Reconstructing long-term trends among women born in 1900-1972 Tomáš Sobotka Vienna Institute of Demography (Austrian Academy of Sciences), Wittgenstein Centre for Demography and

More information

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States 8 10 September 2014 Hammamet, Tunisia MEETING REPORT WHO MEETING ON STRENGTHENING

More information

Overall survival: 1 st line therapy

Overall survival: 1 st line therapy 1 3 Overall survival: 1 st line therapy 2-year OS phase III studies mm Prices per month of oncology medicin Bloomberg Business weekly 26 Feb 2015 Presented By Veena Shankaran at 2016 ASCO Annual Meeting

More information

Table 6.1 Summary information for colorectal cancer in Ireland,

Table 6.1 Summary information for colorectal cancer in Ireland, 6 Colorectal cancer 6.1 Summary Colorectal cancer is the second most common cancer in Ireland (excluding non-melanoma skin cancer). It accounts for 12% of all malignant neoplasia in females and 15% in

More information

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS). Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation),

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation Wild birds and the risk of a pandemic FAO/OIE International Scientific Conference on Avian Influenza and Wild Birds Rome, 31 May, 2006 Caroline S. Brown Technical Officer, Communicable Diseases Surveillance

More information

AIDS by the Numbers: Where Do We Stand with ? Peter Ghys, UNAIDS

AIDS by the Numbers: Where Do We Stand with ? Peter Ghys, UNAIDS AIDS by the Numbers: Where Do We Stand with 90-90-90? Peter Ghys, UNAIDS ACHIEVING THE 90 90 90 TARGETS, 2016 FIGURE 3.2. COUNTRIES THAT HAVE ACHIEVED THE 90 90 90 TARGETS OR ARE NEAR TO ACHIEVING THEM,

More information